Felipe V. Gomes

4.8k total citations
96 papers, 3.5k citations indexed

About

Felipe V. Gomes is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Behavioral Neuroscience. According to data from OpenAlex, Felipe V. Gomes has authored 96 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cellular and Molecular Neuroscience, 37 papers in Pharmacology and 23 papers in Behavioral Neuroscience. Recurrent topics in Felipe V. Gomes's work include Neurotransmitter Receptor Influence on Behavior (40 papers), Cannabis and Cannabinoid Research (37 papers) and Neuroscience and Neuropharmacology Research (30 papers). Felipe V. Gomes is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (40 papers), Cannabis and Cannabinoid Research (37 papers) and Neuroscience and Neuropharmacology Research (30 papers). Felipe V. Gomes collaborates with scholars based in Brazil, United States and Israel. Felipe V. Gomes's co-authors include Francisco Silveira Guimarães, Anthony A. Grace, Leonardo B.M. Resstel, Elaine Aparecida Del Bel, Alline C. Campos, Pablo García, S. Carneiro, J.L.R. Pereira, Fabrício A. Moreira and Fernando Morgan de Aguiar Corrêa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biological Psychiatry.

In The Last Decade

Felipe V. Gomes

92 papers receiving 3.5k citations

Peers

Felipe V. Gomes
Michela Marinelli United States
Rongjian Liu China
D. J. Sanger France
Márcio Flávio Dutra Moraes Brazil
Álvaro Díaz Spain
Vladimir Coric United States
Jürgen Sandkühler Austria
Christoph Lauer Germany
William A. Hewlett United States
Abbas Haghparast Iran
Michela Marinelli United States
Felipe V. Gomes
Citations per year, relative to Felipe V. Gomes Felipe V. Gomes (= 1×) peers Michela Marinelli

Countries citing papers authored by Felipe V. Gomes

Since Specialization
Citations

This map shows the geographic impact of Felipe V. Gomes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe V. Gomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe V. Gomes more than expected).

Fields of papers citing papers by Felipe V. Gomes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felipe V. Gomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe V. Gomes. The network helps show where Felipe V. Gomes may publish in the future.

Co-authorship network of co-authors of Felipe V. Gomes

This figure shows the co-authorship network connecting the top 25 collaborators of Felipe V. Gomes. A scholar is included among the top collaborators of Felipe V. Gomes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felipe V. Gomes. Felipe V. Gomes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Felipe V., et al.. (2024). Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies. Schizophrenia Research. 271. 100–109. 5 indexed citations
2.
Issy, Ana Carolina, et al.. (2024). Cannabidiol attenuates prepulse inhibition disruption by facilitating TRPV1 and 5-HT1A receptor-mediated neurotransmission. Pharmacology Biochemistry and Behavior. 245. 173879–173879. 4 indexed citations
3.
Uliana, Daniela L., et al.. (2024). The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology. 228. 116298–116298. 24 indexed citations
4.
Guimarães, Francisco Silveira, et al.. (2024). Cannabidiol as an antipsychotic drug. International review of neurobiology. 177. 295–317. 2 indexed citations
5.
Gomes, Lucas Carvalho, et al.. (2024). HANSENÍASE NO ESTADO DO PARÁ: PERFIL CLÍNICO EPIDEMIOLÓGICO ANTES E DEPOIS DA COVID-19. Revista fisio&terapia.. 10–11.
6.
Gomes, Felipe V., et al.. (2024). Perineuronal nets as regulators of parvalbumin interneuron function: Factors implicated in their formation and degradation. Basic & Clinical Pharmacology & Toxicology. 134(5). 614–628. 10 indexed citations
7.
Guimarães, Francisco Silveira, et al.. (2023). Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors. Behavioural Brain Research. 450. 114504–114504. 5 indexed citations
8.
Andrade, Lídia M., et al.. (2023). CANNABIDIOL ATTENUATES BEHAVIORAL AND ELECTROPHYSIOLOGICAL CHANGES IN THE MAM MODEL OF SCHIZOPHRENIA. IBRO Neuroscience Reports. 15. S557–S557. 1 indexed citations
9.
Sales, Amanda J., et al.. (2023). Doxycycline diminishes the rewarding and psychomotor effects induced by morphine and cocaine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 128. 110870–110870. 2 indexed citations
10.
Costa, Tiago J., Diego A. Duarte, Cláudio M. Costa-Neto, et al.. (2023). Carotid dysfunction in senescent female mice is mediated by increased α1A‐adrenoceptor activity and COX-derived vasoconstrictor prostanoids. American Journal of Physiology-Heart and Circulatory Physiology. 324(4). H417–H429. 6 indexed citations
11.
Gomes, Felipe V., Diana Cash, Daniela L. Uliana, et al.. (2021). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology. 47(3). 687–695. 9 indexed citations
12.
Gomes, Felipe V., et al.. (2020). Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors. Pharmacological Research. 156. 104749–104749. 64 indexed citations
13.
Guimarães, Francisco Silveira, et al.. (2020). Are CB2 Receptors a New Target for Schizophrenia Treatment?. Frontiers in Psychiatry. 11. 587154–587154. 22 indexed citations
14.
Gomes, Felipe V., et al.. (2019). Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure. European Neuropsychopharmacology. 29(10). 1127–1137. 30 indexed citations
15.
Silva, Nicole Rodrigues da, Felipe V. Gomes, Miriam M. Fonseca, et al.. (2017). Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 79(Pt B). 369–377. 37 indexed citations
16.
Gomes, Felipe V., Millie Rincón‐Cortés, & Anthony A. Grace. (2016). Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model. Neuroscience & Biobehavioral Reviews. 70. 260–270. 97 indexed citations
17.
Lisboa, Sabrina F., Felipe V. Gomes, Daniela L. Uliana, et al.. (2015). Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System. The International Journal of Neuropsychopharmacology. 18(8). pyv005–pyv005. 38 indexed citations
18.
Gomes, Felipe V., et al.. (2012). Both α1‐ and β1‐adrenoceptors in the bed nucleus of the stria terminalis are involved in the expression of conditioned contextual fear. British Journal of Pharmacology. 167(1). 207–221. 24 indexed citations
19.
Gomes, Felipe V., Plínio Casarotto, Leonardo B.M. Resstel, & Francisco Silveira Guimarães. (2010). Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(2). 434–438. 59 indexed citations
20.
Gomes, Felipe V., et al.. (2009). Descrição e avaliação do sistema de medicação do serviço de farmácia em um hospital universitário. Latin American Journal of Pharmacy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Marinelli Breakdown of academic impact, for papers by Rongjian Liu Breakdown of academic impact, for papers by D. J. Sanger Breakdown of academic impact, for papers by Márcio Flávio Dutra Moraes Breakdown of academic impact, for papers by Álvaro Díaz Breakdown of academic impact, for papers by Vladimir Coric Breakdown of academic impact, for papers by Jürgen Sandkühler Breakdown of academic impact, for papers by Christoph Lauer Breakdown of academic impact, for papers by William A. Hewlett Breakdown of academic impact, for papers by Abbas Haghparast
Rankless by CCL
2026